CoverageForm 410-K10-Q8-K13D13G13F

OM Outset Medical, Inc. - 8-K

Filed May 29, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-26-248237
5.02

Item 5.02 - Departure/Election of Directors or Certain Officers

77 words

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 26, 2026, Marc Nash informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities. Mr. Nash’s departure is not due to any dispute or disagreement with the Company or its management.